A new weight-loss medication got an overwhelming endorsement on Wednesday from FDA?s Endocrinologic and Metabolic Drugs Advisory Committee. The committee voted 20-2 in favor of approving phentermine/topiramate (Qnexa, Vivus).F. StaffAdvanstar Communications Inc...
An initial review by the U.S. Food and Drug Administration has found the diet pill Qnexa to be safe and effective, according to an FDA report released Tuesday morning.
Lorqess is one of three weight-loss drugs vying to be the first new diet drug approved in a decade. The FDA is expected to make a decision on Qnexa -- a low-dose combination of phentermine and topiramate -- in July. Like Lorqess, Qnexa was at first rejected by the FDA, but Vivus...
Morning or Nighttime Medication Dosing—Does It Matter in the Treatment of Hypertension? Sandra J. Taler, MD JAMA Research Letter Changes in Physical and Mental Health After the End of SNAP Emergency Allotments Michael Liu, MPhil; Daniel Y. Johnson, BA; Sara N. Bleich, PhD; et al. ...
Medication Abortion Between 14 0/7 and 27 6/7 Weeks of Gestation Society:Society of Family Planning (SFP) Published:October 9, 2023 Evaluating New Fever in Adult Patients in the ICU Society:Infectious Diseases Society of America (IDSA); Society of Critical Care Medicine (SCCM) ...
The obesity medications help overcome a biological mechanism that kicks in when people diet, triggering a coordinated effort by the body to prevent weight loss. Potentially serious side effects "That is a real physical phenomenon," Aronne said. "There are a number of hormones that respond to re...
(RxWiki News) The US Food and Drug Administration (FDA) has approved a newdiabetesmedication. This new approval is found under the namesRybelsus(brand name) andsemaglutide(active ingredient). The FDA approved semaglutide to treat adults withtype 2 diabetesin combination with diet and exercise. ...
gov/medwatch or call 1-800-FDA-1088. For more information, please see Prescribing Information and Medication Guide. CL-JAR-100057 01.27.2020 Boehringer Ingelheim and Eli Lilly and CompanyIn January 2011, Boehringer Ingelheim and Eli Li...
FDA-approved 1 dose needed Novavaxprotein vaccine FDA-authorized for emergency use 1 dose needed 2 doses needed only for patients who’ve never received any COVID vaccine Medicareand many private health insurers cover the cost of the vaccine. Uninsured adults may be eligible forfree vaccinationat...
The first cholesterol-lowering medication in a new class of drugs—proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors—has received FDA approval.Alirocumab, marketed as Praluent, is approved for use along with diet and statin therapy by adults with heterozygous familial ...